Caplin Point Laboratories Ltd (BOM:524742)
₹ 2010.85 -106.65 (-5.04%) Market Cap: 152.85 Bil Enterprise Value: 144.14 Bil PE Ratio: 31.03 PB Ratio: 6.01 GF Score: 98/100

Q3 2022 Caplin Point Laboratories Ltd Earnings Call Transcript

Feb 03, 2022 / 10:00AM GMT
Release Date Price: ₹828.7 (+0.33%)
Operator

Ladies and gentlemen, good day and welcome to the Caplin Point Laboratories Q3 FY '22 Earnings Conference Call, hosted by Batlivala & Karani Securities India Pvt. Ltd. (Operator Instructions)

Please note that this conference is being recorded. I now hand the conference over to Ms. Alka Katiyar from Batlivala & Karani Securities India Pvt. Ltd. Thank you. And over to you, ma'am.

Alka Katiyar
Batlivala & Karani Securities India Pvt. Ltd., Research Division - Research Analyst

Thank you, and good afternoon, everyone. On behalf of B&K Securities, I would like to welcome you all for our 3Q FY 2022 Earnings Conference Call of Caplin Point Laboratories Limited.

From the company today, we have with us the senior management team, including Mr. C.C. Paarthipan; the Chairman; Mr. Vivek Partheeban, the CFO (sic) [COO]; Mr. -- Dr. Sridhar Ganesan, the MD; Mr. D. Muralidharan, the CFO; and Mr. M. Sathya Narayanan, Deputy Chief Financial Officer.

I would now like to hand over the call to the management for their initial comments.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot